000 01494 a2200397 4500
005 20250513083306.0
264 0 _c19960119
008 199601s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-199512000-00009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIngle, J N
245 0 0 _aEvaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cDec 1995
300 _a498-501 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Alkylating
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCystitis
_xchemically induced
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadministration & dosage
650 0 4 _aMesna
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRemission Induction
700 1 _aKrook, J E
700 1 _aMailliard, J A
700 1 _aHartmann, L C
700 1 _aWieand, H S
773 0 _tAmerican journal of clinical oncology
_gvol. 18
_gno. 6
_gp. 498-501
856 4 0 _uhttps://doi.org/10.1097/00000421-199512000-00009
_zAvailable from publisher's website
999 _c8525300
_d8525300